A PARP inhibitors in the treatment of breast cancer - A Review of literature
Introduction Breast cancer is the most common malignancy in women in developed countries. It also occurs in men. The primary therapy for these cancers is surgery; chemotherapy, radiation therapy, hormone therapy, or immunotherapy are also used. More and better treatments are being sought for this d...
Saved in:
Main Authors: | Jagoda Niewiadomska (Author), Borys Bondos (Author), Aleksandra Stępień (Author), Alicja Paluch (Author), Jakub Skrzypek (Author), Aleksandra Niekra (Author), Łukasz Fussek (Author), Robert Kochan (Author), Ewelina Wieczorek (Author), Kacper Lee (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the use of PARP inhibitor therapy for breast cancer
by: Kelly E McCann, et al.
Published: (2018) -
PARP inhibitors are a new area in the treatment of breast cancer
by: V. P. Letyagin
Published: (2014) -
PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
by: D. S. Dolgasheva, et al.
Published: (2020) -
Is there an epigenetic component underlying the resistance of triple-negative breast cancers to PARP inhibitors?
by: Amanda eLovato, et al.
Published: (2012) -
Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer
by: Mariya Yordanova, et al.
Published: (2021)